JY
LVTX

Jeff Yass’s LAVA Therapeutics LVTX Stock Holding History

Jeff Yass’s Portfolio LVTX Stock Details LVTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-36,200
Closed -$56.5K – 13076
2025
Q3 		$56.5K Buy
+36,200
New +$54.1K ﹤0.01% 11825

Jeff Yass's LVTX Position: Q4 2024 in Review

Jeff Yass sold out of LAVA Therapeutics (LVTX) in Q4 2024, closing a stake of 48,205 shares — an estimated $80K sold.

Jeff Yass first reported a position in LVTX in Q3 2024 and held it in 1 quarter. The position peaked at $80K in Q3 2024. 22 funds tracked by Wall St. Rank hold LVTX as of Q4 2024.

  • Jeff Yass reported no remaining LAVA Therapeutics position as of Q4 2024 after selling out during the quarter.
  • Jeff Yass sold 48,205 LAVA Therapeutics shares in Q4 2024, an estimated $80K.
  • Jeff Yass first reported a position in LAVA Therapeutics in Q3 2024 and held it in 1 quarter.
  • Jeff Yass's LAVA Therapeutics position peaked at $80K in Q3 2024.
  • 22 funds tracked by Wall St. Rank held LAVA Therapeutics as of Q4 2024.

Based on Susquehanna International Group's 13F filing for Q4 2024, filed 14 Feb 2025.